Multimodal Monitoring in the Perioperative Period (2)

||||| Like It 0 Like |||||

Cerebral and tissue oxygen monitoring as part of the MMM strategy
It has been stated that: “The proper management of brain oxygenation should be one of the principal endpoints of all anaesthesia procedures yet the brain remains one of the least monitored organs during clinical anaesthesiology” [29]. Near infrared spectroscopy (NIRS) using a reflectance technique can be used to measure cerebral tissue oxygenation to a depth of about 2.5 cm below the measuring electrodes, which are usually placed on the forehead. Regional brain oxygen saturation (rSO2 or ScO2) also reflects overall tissue rather than arterial oxygen saturation or Spo2, as assessed with a pulse oximeter [30]. Cerebral rSO2 is venous weighted with a characteristic value in healthy patients of about 70%. A detailed consideration of this technology is outside the scope of this article, so the reader is referred to the excellent reviews by Murkin and Arango [29] and Scheeren et al. [31] Cerebral oximeters work best as trend monitors rather than absolute monitors [29], emphasising the importance of obtaining a pre-induction value in
elective patients.

Apart from those neurological conditions where brain oxygenation is obviously suspect – for example, carotid endarterectomy [32] – many operations on the elderly may lead to reductions in rSO2 [33] and poor outcome [34]. The challenge is to define suitable interventions if rSO2 diminishes by more than about 10% from the starting value. An MMM strategy that maintains flow and DO2 almost always ensures that rSO2 will remain at or above the pre-induction level [35].

Consideration of the role of cerebral oximetry in cardiac surgery, where its clinical applicability is greatest, is outside the scope of this article. However, its true role remains a matter of debate [36], although several studies have indicated possible benefits [37, 38].

My own experience with this monitoring technology amounts to nearly 1,000 cases. These have mainly included high-risk cases with an average American Society of Anesthesiologists (ASA) class of 3 or above, of long duration, where the build-up of oxygen debt was considered potentially a problem, and in the elderly population (average age, 68 years), where oxygen debt was likely to have caused the most problems. Maintaining tissue oxygenation should reduce complications [31]. A recent review has even suggested that cerebral and tissue oximetry should become the standard monitor of future practice [39].

Depth of anaesthesia monitoring as part of the MMM strategy
Figure 1 indicates why monitoring the effect of the anaesthetic on cortical suppression is important for high-risk patients but may not be as important for fit and healthy patients. Looking along the x-axis, from left to right, increasing anaesthetic concentration will inevitably lead to cardiovascular depression and decreased DO2. This obviously has implications, in that there may be a build-up of oxygen debt, complications in the postoperative period and poor outcome. Neuronal toxicity is also increasingly likely as the concentration of anaesthetic increases [40]. Conversely, moving from right to left along the x-axis, too little anaesthetic will obviously increase the risk of a patient’s intraoperative awareness and explicit recall; the benefits of anaesthetic neuronal protection may also be lost. Consequently, there is a balance to be struck. The dashed curve indicates a low-risk patient where the target anaesthetic concentration is rather broad and the implications of a small clinical misjudgement of the depth of anaesthesia (as indicated by the shallowness of the curve) means that the patient is unlikely to be unduly harmed. However, the situation with the elderly or high-risk patient is different, and the amount of anaesthetic required will be less, with a narrower margin between too light and too deep anaesthesia. Ten years’ experience with the BIS monitor in high-risk patients – especially the elderly – has shown that there is a fourfold variation in propofol anaesthesia requirement [35], which cannot be predicted by clinical signs alone.

Green fig1

Excessive depth of anaesthesia is harmful
Monitoring with BIS is now recommended by NICE in the UK for high-risk patients and the latest Recommendations for Standards of Monitoring during Anaesthesia and Recovery 2015 from the Association of Anaesthetists of Great Britain and Ireland (AAGBI) include a requirement for depth of anaesthesia monitoring during total intravenous anaesthesia when neuromuscular blockers are used [41]. Evidence shows that BIS-guided anaesthesia decreases postoperative delirium [42] and cognitive decline (POCD) [43], and in the US it is recommended to reduce the incidence of delirium in older patients [44]. In a pilot trial, combining BIS and cerebral oximetry led to a reduction in POCD and significantly lower levels of S100 B, an indicator of neuronal damage, in the intervention group [45].

Use of an MMM strategy in high-risk patients and high-risk surgery
Recent guidelines for managing patients with a proximal femoral fracture suggest that monitoring of cardiac output, depth of anaesthesia and cerebral oxygenation should be considered alongside a basic monitoring setup in this high-risk group [46]. An observational case series in 120 patients who were undergoing major peripheral vascular surgery at very high risk of postoperative complications suggests that there are benefits in using
the MMM strategy, in terms of a reduction in 30-day mortality (to only 0.8%) and in amputation rate (to 2% at 1 year), as well as a reduced requirement for postoperative care in the HDU/ICU (to only 8%) [35].

Future randomised controlled trials using flow monitoring should consider using an MMM strategy. SV maximisation and GDT to a population-based target of 600 ml/m2 body surface area alongside liberal fluids should be abandoned [6, 47, 48].

The future
It should become routine practice to use an MMM strategy to try to maintain perioperative DO2, in order to minimise build-up of oxygen debt, as a key strategy for ensuring successful outcomes in high-risk surgical patients. With the monitoring technology currently available, this is now achievable. As visualised in Figure 2, the reduction in oxygen debt can be achieved using an MMM approach where flow (e.g. LiDCO RapidTM), depth of anaesthesia (e.g. BISTM, Medtronic, Narcotrend®, MT MonitorTechnik GmbH & Co. KG or NeuroSENSE, NeuroWave Inc) and cerebral oximetry (e.g. INVOS, Medtronic) monitors are used alongside conventional intraoperative monitoring. The recent arrival of finger-based, non-invasive, continuous blood-pressure monitoring [49], with provision for converting the waveform into flow, means that all high-risk patients could benefit from this strategy in the future.

The future updated

MMM has advantages for the anaesthetist, the patient and the healthcare system. It pinpoints very clearly the physiological changes associated with anaesthesia and surgery, from pre-induction to post-anaesthesia care units. It allows intervention strategies to be more focused and physiologically appropriate, and enables a more rational approach to intraoperative haemodynamic management. As we gain greater insight into intraoperative physiological change in our patients we can individualise management using strategies designed to centre on minimising the build-up of oxygen debt, and this should therefore improve outcomes. The burgeoning of the elderly, high-risk patient population mandates a new perioperative anaesthetic management strategy. MMM has the potential to reduce the requirement for expensive HDU and ICU facilities, decrease hospital length of stay and therefore reduce the cost of perioperative care by reducing patient morbidity and mortality.


  1. Sury MR et al. The state of UK anaesthesia: a survey of National Health Service activity in 2013. Br J Anaesth 2014; 113(4): 575−584
  2. Pearse RM et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet 2012; 380(9847): 1059−1065
  3. Story DA et al. Complications and mortality in older surgical patients in Australia and New Zealand (the REASON study): a multicentre, prospective, observational study*. Anaesthesia 2010; 65(10): 1022−1030
  4. Kirov MY et al. Perioperative haemodynamic therapy. Curr Opin Crit Care 2010; 16(4): 384−392
  5. Pearse RM et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA 2014; 311(21): 2181−2190
  6. Lai CW et al. Randomized controlled trial of stroke volume optimization during elective major abdominal surgery in patients stratified by aerobic fitness. Br J Anaesth 2015; 115(4): 578−589
  7. Green D and Paklet L. Latest developments in peri-operative monitoring of the high-risk major surgery patient. Int J Surg 2010; 8: 90−99
  8. Bidd H et al. Using bispectral index and cerebral oximetry to guide hemodynamic therapy in high-risk surgical patients. Perioper Med (Lond) 2013; 2(11): 1−9
  9. Monk TG et al. Association between Intraoperative Hypotension and Hypertension and 30-day Postoperative Mortality in Noncardiac Surgery. Anesthesiology 2015; 123(2): 307−319
  10. Shires T et al. Acute change in extracellular fluids associated with major surgical procedures. Ann Surg 1961; 154(5): 803−810
  11. Brandstrup B et al. Hemorrhage and operation cause a contraction of the extracellular space needing replacement–evidence and implications? A systematic review. Surgery 2006; 139(3): 419−432
  12. Chappell D et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109(4): 723−740
  13. Jacob M et al. The ‘third space’–fact or fiction? Best practice & research. Clinical Anaesthesiology 2009; 23(2): 145−157
  14. Minto G and Mythen MG. Perioperative fluid management: science, art or random chaos? Br J Anaesthesia 2015; 114(5): 717−721
  15. Marik PE. Iatrogenic salt water drowning and the hazards of a high central venous pressure. Ann Intensive Care 2014; 4: 21
  16. Wuethrich PY et al. Restrictive Deferred Hydration Combined with Preemptive Norepinephrine Infusion during Radical Cystectomy Reduces Postoperative Complications and Hospitalization Time: A Randomized Clinical Trial. Anesthesiology 2014; 120(2): 365−377
  17. Moller Petrun A and Kamenik M. Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate: a double-blind, randomized, clinical trial. Br J Anaesth 2013; 110(3): 388−396
  18. Goodchild CS and Serrao JM. Cardiovascular effects of propofol in the anaesthetized dog. Br J Anaesth 1989; 63(1): 87−92
  19. Wolff CB and Green DW. Clarification of the circulatory patho-physiology of anaesthesia – Implications for high-risk surgical patients. Int J Surg 2014; 12(12): 1348−1356
  20. Green DW. Cardiac output decrease and propofol: what is the mechanism? Br J Anaesth 2015; 114(1): 163−164
  21. National Institute for Health and Clinical Excellence. Medical technologies guidance MTG3: CardioQODM oesophageal doppler monitor.,, 2011
  22. Ghosh S et al. NICE guidance on CardioQ(TM) oesophageal Doppler monitoring. Anaesthesia 2011; 669(12): 1081−1083
  23. Singer M. Oesophageal Doppler monitoring: a not-so-NICE editorial. Anaesthesia 2012; 67(4): 428-30; author reply 431-432
  24. Grocott MP et al. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review. Br J Anaesth 2013; 111(4): 535−548
  25. Minto G and Struthers R. Stroke volume optimisation: is the fairy tale over? Anaesthesia 2014; 69(4): 291−296
  26. Green DW: Role of Multimodal Monitoring (MMM) in the Perioperative Period: Improving Outcomes in High Risk Surgical Patients, Chapter 13 in: Perioperative Medicine – Current Controversies. Edited by Stuart-Smith K. Springer International Publishing Switzerland, Springer, 2016
  27. Shoemaker WC et al. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest 1992; 102(1): 208−215
  28. Ackland GL et al. Individualised oxygen delivery targeted haemodynamic therapy in high-risk surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trial. Lancet Respir Med 2015; 3(1): 33−41
  29. Murkin JM and Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth 2009; 103 Suppl 1: i3−i13
  30. Murkin JM: Cerebral oximetry: monitoring the brain as the index organ. Anesthesiology 2011; 114: 12−13
  31. Scheeren TW et al. Monitoring tissue oxygenation by near infrared spectroscopy (NIRS): background and current applications. J Clin Monit Comput 2012; 26(4): 279−287
  32. Ritter JC et al. The role of cerebral oximetry in combination with awake testing in patients undergoing carotid endarterectomy under local anaesthesia. Eur J Vasc Endovasc Surg 2011; 41(5): 599−605
  33. Green DW. A retrospective study of changes in cerebral oxygenation using a cerebral oximeter in older patients undergoing prolonged major abdominal surgery. Eur J Anaesthesiol 2007; 24: 230−234
  34. Casati A et al. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg 2005; 101: 740−747
  35. Green D et al. Multimodal intraoperative monitoring: An observational case series in high risk patients undergoing major peripheral vascular surgery. Int J Surg 2014; 12(3): 231−236
  36. Zheng F et al. Cerebral near-infrared spectroscopy monitoring and neurologic outcomes in adult cardiac surgery patients: a systematic review. Anesth Analg 2013; 116(3): 663−676
  37. Murkin JM et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg 2007; 104(1): 51−58
  38. Slater JP. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg 2009; 87(1): 36−44; discussion 44−45
  39. Moerman A and De Hert S. Cerebral oximetry: the standard monitor of the future? Curr Opin Anaesthesiol 2015; 28(6): 703−709
  40. Jevtovic-Todorovic V et al. Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth 2013; 111(2): 143−151
  41. Checketts MR et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2016; 71: 85−93
  42. Radtke FM et al. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth 2013; 110 Suppl 1: i98−105
  43. Chan MT et al. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol 2013; 25(1): 33−42
  44. American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults: Postoperative delirium in older adults: best practice statement from the American Geriatrics Society. J Am Coll Surg 2015; 220(2): 136−148.e1
  45. Ballard C et al. Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One 2012; 7(6): e37410
  46. Griffiths R et al. Management of proximal femoral fractures 2011: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2012; 67(1): 85−98
  47. Vincent JL et al. Clinical review: Update on hemodynamic monitoring–a consensus of 16. Crit Care 2011; 15(4): 229
  48. Challand C et al. Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. Br J Anaesth 2012; 108(1): 53−62
  49. Saugel B and Reuter DA: III. Are we ready for the age of non-invasive haemodynamic monitoring? Br J Anaesth 2014; 113(3): 340−343


Return to previous page

Download full article here:

Return to the main table of contents by clicking here

Leave a Reply

Scroll to top